Clinical site monitoring in human subjects for an for an extramural study to evaluate the ability of dermal open flow microperfusion (dofm) for bioequivalence (be) testing of different diclofenac…
Ended Awarded Last action
- Contract number
- 75F40122F19029
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $9,354
Award facts
- Contract value 100% obligated
- $9,353.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,839 | |
| Original award | $12,193 |
About this award
This federal contract award, valued at $9,353.97, was issued by the Food and Drug Administration (FDA) to The Emmes Company LLC, a for-profit limited liability company that provides clinical research services. The contract is for clinical site monitoring in human subjects to evaluate the ability of dermal open flow microperfusion (DOFM) for bioequivalence testing of different diclofenac products at Joanneum Research in Graz, Austria. This is a firm fixed-price delivery order contract with an ultimate completion date of August 8, 2023. The Emmes Company LLC is an experienced provider of biostatistical, epidemiological, data management, and logistical support for clinical and laboratory research initiatives, having secured numerous prime and sub-awards from various National Institutes of Health (NIH) institutes as well as the FDA. This contract award is not set aside for any specific business type.
Description
Clinical site monitoring in human subjects for an for an extramural study to evaluate the ability of dermal open flow microperfusion (dofm) for bioequivalence (be) testing of different diclofenac products at joanneum research, graz, austria. This STU
Quick answers
Who was awarded contract 75F40122F19029?
75F40122F19029 was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on August 9, 2022.
How much is contract 75F40122F19029 worth?
The government has obligated $9,354 on 75F40122F19029.
Is contract 75F40122F19029 an order under another contract?
Yes. 75F40122F19029 is a delivery order under HHSF223201710031I, an indefinite delivery contract.
Was contract 75F40122F19029 competed?
The extent of competition for 75F40122F19029 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award